atazanavir sulfate has been researched along with Lipodystrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akita, S; Hirano, A; Ohtsuru, A; Suzuki, K; Yamashita, S; Yoshimoto, H | 1 |
| Currie, A; Fiedorek, FT; Grasela, DM; Haas, DW; Hodder, SL; Noor, MA; O'Mara, E; Parker, RA | 1 |
1 trial(s) available for atazanavir sulfate and Lipodystrophy
| Article | Year |
|---|---|
The effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adults.
Topics: Adult; Analysis of Variance; Atazanavir Sulfate; Cross-Over Studies; Double-Blind Method; Energy Metabolism; Fatty Acids, Nonesterified; Glycogen; HIV Protease Inhibitors; HIV Seronegativity; Humans; Insulin Resistance; Lipids; Lipodystrophy; Lopinavir; Oligopeptides; Pyridines; Pyrimidinones | 2004 |
1 other study(ies) available for atazanavir sulfate and Lipodystrophy
| Article | Year |
|---|---|
Cellular Mechanism Underlying Highly-Active or Antiretroviral Therapy-Induced Lipodystrophy: Atazanavir, a Protease Inhibitor, Compromises Adipogenic Conversion of Adipose-Derived Stem/Progenitor Cells through Accelerating ER Stress-Mediated Cell Death in
Topics: Adipocytes; Adipogenesis; Adipose Tissue; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Apoptosis; Atazanavir Sulfate; Cell Death; Cell Differentiation; Cells, Cultured; DNA Damage; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Humans; Lipid Droplets; Lipodystrophy; Oxidative Stress; Protease Inhibitors; Reactive Oxygen Species; Stem Cells; Transcription Factor CHOP | 2021 |